Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Apr 5, 2021
Open Peer Review Period: Apr 5, 2021 - May 31, 2021
Date Accepted: Dec 16, 2021
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Internet-Delivered Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Nationwide Routine Care: Effectiveness Study

Ritola V, Lipsanen J, Pihlaja S, Gummerus EM, Stenberg JH, Joffe G

Internet-Delivered Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Nationwide Routine Care: Effectiveness Study

J Med Internet Res 2022;24(3):e29384

DOI: 10.2196/29384

PMID: 35323119

PMCID: 8990365

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Internet-delivered Cognitive-Behavioral Therapy for Generalized Anxiety Disorder: Its Effectiveness in Nationwide Routine Care

  • Ville Ritola; 
  • Jari Lipsanen; 
  • Satu Pihlaja; 
  • Eero-Matti Gummerus; 
  • Jan-Henry Stenberg; 
  • Grigori Joffe

ABSTRACT

Background:

Internet-delivered, therapist-supported Cognitive Behavioral Therapy (iCBT) is efficacious for Generalized Anxiety Disorder (GAD), but few studies have as yet reported its effectiveness in routine care.

Objective:

To examine whether a new 12-session iCBT program for GAD is effective in nationwide routine care.

Methods:

The program was free-of-charge for patients and its completion time was unrestricted. A specialized iCBT clinic delivered iCBT to 1,099 physician-referred patients. We measured symptoms with online questionnaires. The primary measure of anxiety was the GAD-7; secondary measures were, for pathological worry, the Penn State Worry Questionnaire (PSWQ) and, for anxiety and impairment, the Overall Anxiety Severity and Impairment Scale (OASIS).

Results:

Patients completed a mean 7.8 (65.1%) of 12 sessions, and 44.1% of patients completed all sessions. Effect size in the whole sample for GAD-7 was large (d=0.96; 95%CI: 0.87-1.05). For completers, effect sizes were very large, d=1.34 (95%CI: 1.25-1.53) for GAD-7, d=1.14 (95%CI:1.00-1.27) for PSWQ, and 1.23 (95%CI:1.09-1.37) for OASIS. Patients who dropped out also benefited from the treatment. Greater symptomatic relief (GAD-7) was associated with more completed sessions, older age, and being referred from private or occupational care. Of 894 patients with baseline GAD-7 score ≥10, those achieving a reliable recovery amounted to 421 (47.1%).

Conclusions:

This nationwide, free-of-charge, therapist-supported HUS-iCBT for GAD was effective in routine care, but further research must establish comparative effectiveness and optimize the design of iCBT for GAD for different patient groups and individual patients. Clinical Trial: Nationwide internet-delivered computer-assisted cognitive-behavioral therapy (iCBT) for psychiatric disorders. https://www.isrctn.com/ISRCTN55123131


 Citation

Please cite as:

Ritola V, Lipsanen J, Pihlaja S, Gummerus EM, Stenberg JH, Joffe G

Internet-Delivered Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Nationwide Routine Care: Effectiveness Study

J Med Internet Res 2022;24(3):e29384

DOI: 10.2196/29384

PMID: 35323119

PMCID: 8990365

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.